IESE (España)
-
Riverside: The Acquisition of Euromed : Investment Process of a Private Equity
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962-EFinanceIn December 2015, Riverside PE (private equity) had to present a blind offer for the acquisition of Euromed, together with the financing of the operation. Euromed produces active ingredients for medical use. Euromed enjoys a profitable niche (good margins), with few competitors, high barriers and promising growth opportunities. It has sales of around 43 million euros, with 300 clients in 35 countries.Starting at €8.20
-
Riverside: The Acquisition of Euromed : Investment Process of a Private Equity (Portuguese Version, Brazil)
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962-PBFinanceIn December 2015, Riverside PE (private equity) had to present a blind offer for the acquisition of Euromed, together with the financing of the operation. Euromed produces active ingredients for medical use. Euromed enjoys a profitable niche (good margins), with few competitors, high barriers and promising growth opportunities. It has sales of around 43 million euros, with 300 clients in 35 countries. This case is an updated version of the case ...Starting at €8.20
-
TelePizza 1999: Value and Price
Forman C.; Palencia, LuisCase C-731-EAccounting and ControlIn June 1999 the decision by TelePizza's CEO and main shareholder to sell 5% of his stake in the company stock prompted a 9% drop in the share price. If it was a market overreaction and the fundamentals were unchanged, it could have been a good buy opportunity. The case can be used to analyze the drivers of value (profitability and growth) and revise current market price in view of their sustainability.Starting at €8.20
-
Riverside: la compra de Euromed: Proceso inversor de una private equity
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962FinanceEn diciembre de 2015 Riverside PE (private equity), tiene que presentar una oferta ciega para la adquisición de Euromed, junto con la financiación de la operación. Euromed produce ingredientes activos para uso médico. Euromed disfruta de un buen nicho rentable (buenos márgenes), con pocos competidores, altas barreras y prometedoras oportunidades de crecimiento. Ventas alrededor de 43 millones de euros, con 300 clientes en 35 países.Starting at €8.20
-
Riverside: The Acquisition of Euromed : Investment Process of a Private Equity (Portuguese version, Portugal)
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962-PPFinanceIn December 2015, Riverside PE (private equity) had to present a blind offer for the acquisition of Euromed, together with the financing of the operation. Euromed produces active ingredients for medical use. Euromed enjoys a profitable niche (good margins), with few competitors, high barriers and promising growth opportunities. It has sales of around 43 million euros, with 300 clients in 35 countries.Starting at €8.20
-
GAMESA, October 2004. The Valuation of Wind
Forman C.; Palencia, LuisCase C-735-EAccounting and ControlThe case provides information to assess the 2004 market valuation of GAMESA, e11 per share at the time. GAMESA has four lines of business, manufacturing WTG (wind turbine generators), developing and selling wind farms, aeronautical manufacturing, and services. Each segment has its own valuation peculiarities.Starting at €8.20